The sad plight of cell therapy for heart failure: causes and consequences.
作者信息
Bolli Roberto, Tang Xian-Liang
机构信息
Institute of Molecular Cardiology, University of Louisville, Louisville, KY 40292, USA.
出版信息
J Cardiovasc Aging. 2022;2. doi: 10.20517/jca.2022.02. Epub 2022 Mar 2.
Abstract
摘要
相似文献
1
The sad plight of cell therapy for heart failure: causes and consequences.
J Cardiovasc Aging. 2022;2. doi: 10.20517/jca.2022.02. Epub 2022 Mar 2.
2
Cardiac progenitor cells for heart repair.
Cell Death Discov. 2016 Jul 18;2:16052. doi: 10.1038/cddiscovery.2016.52. eCollection 2016.
3
Sudden Death in Patients With Coronary Heart Disease Without Severe Systolic Dysfunction.
JAMA Cardiol. 2018 Jul 1;3(7):591-600. doi: 10.1001/jamacardio.2018.1049.
4
Prepare cells to repair the heart: mesenchymal stem cells for the treatment of heart failure.
Am J Nephrol. 2007;27(3):301-7. doi: 10.1159/000102000. Epub 2007 Apr 25.
5
Hemodynamic and norepinephrine responses to pacing-induced heart failure in conscious sinoaortic-denervated dogs.
J Appl Physiol (1985). 1996 Oct;81(4):1855-62. doi: 10.1152/jappl.1996.81.4.1855.
6
Cardiac Repair and Regeneration: The Value of Cell Therapies.
Eur Cardiol. 2016 Summer;11(1):43-48. doi: 10.15420/ecr.2016:8:1. Epub 2015 Apr 28.
7
Stem cells for heart failure in the aging heart.
Heart Fail Rev. 2010 Sep;15(5):447-56. doi: 10.1007/s10741-010-9160-z.
8
Genesis of myocardial repair with cardiac progenitor cells and tissue engineering.
Heart Asia. 2010 Sep 18;2(1):109-11. doi: 10.1136/ha.2009.001651. eCollection 2010.
9
Repair of ischemic heart disease with novel bone marrow-derived multipotent stem cells.
Cell Cycle. 2005 Jul;4(7):861-4. doi: 10.4161/cc.4.7.1799. Epub 2005 Jul 4.
10
[Stem cell therapy for myocardial regeneration: mechanisms and current clinical applications].
G Ital Cardiol (Rome). 2008 Apr;9(4):234-50.
引用本文的文献
1
Heart-derived endogenous stem cells.
Mol Biol Rep. 2025 Sep 10;52(1):880. doi: 10.1007/s11033-025-11001-4.
2
Long term event-free survival following cell-based therapy in patients with cardiomyopathy: the HYPERION observational cohort.
Stem Cells Transl Med. 2025 May 19;14(5). doi: 10.1093/stcltm/szaf010.
3
Living Nanofiber-Enabled Cardiac Patches for Myocardial Injury.
JACC Basic Transl Sci. 2025 Feb;10(2):227-240. doi: 10.1016/j.jacbts.2024.06.010. Epub 2024 Sep 4.
4
Stem cell therapy for heart failure in the clinics: new perspectives in the era of precision medicine and artificial intelligence.
Front Physiol. 2024 Jan 9;14:1344885. doi: 10.3389/fphys.2023.1344885. eCollection 2023.
5
Cardiopulmonary progenitors facilitate cardiac repair via exosomal transfer of miR-27b-3p targeting the SIK1-CREB1 axis.
Cell Prolif. 2024 May;57(5):e13593. doi: 10.1111/cpr.13593. Epub 2024 Jan 7.
6
Danish phase II trial using adipose tissue derived mesenchymal stromal cells for patients with ischaemic heart failure.
ESC Heart Fail. 2023 Apr;10(2):1170-1183. doi: 10.1002/ehf2.14281. Epub 2023 Jan 13.
本文引用的文献
1
Cell therapy in patients with heart failure: a comprehensive review and emerging concepts.
Cardiovasc Res. 2022 Mar 16;118(4):951-976. doi: 10.1093/cvr/cvab135.
2
A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial.
Eur J Heart Fail. 2021 Apr;23(4):661-674. doi: 10.1002/ejhf.2178. Epub 2021 Apr 13.
3
Comparison of One and Three Intraventricular Injections of Cardiac Progenitor Cells in a Murine Model of Chronic Ischemic Cardiomyopathy.
Stem Cell Rev Rep. 2021 Apr;17(2):604-615. doi: 10.1007/s12015-020-10063-0. Epub 2020 Oct 28.
4
Cell therapy for acute myocardial infarction: Requiescat in Pace.
Eur Heart J. 2020 Oct 7;41(38):3711-3714. doi: 10.1093/eurheartj/ehaa802.
5
After the storm: an objective appraisal of the efficacy of c-kit+ cardiac progenitor cells in preclinical models of heart disease.
Can J Physiol Pharmacol. 2021 Feb;99(2):129-139. doi: 10.1139/cjpp-2020-0406. Epub 2020 Sep 16.
6
The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: the BAMI trial.
Eur Heart J. 2020 Oct 7;41(38):3702-3710. doi: 10.1093/eurheartj/ehaa651.
7
Time to end the war on cell therapy.
Eur J Heart Fail. 2020 May;22(5):893-897. doi: 10.1002/ejhf.1767. Epub 2020 Feb 26.
8
Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association.
Circulation. 2020 Mar 3;141(9):e139-e596. doi: 10.1161/CIR.0000000000000757. Epub 2020 Jan 29.
9
Bone marrow-derived mesenchymal stromal cell treatment in patients with ischaemic heart failure: final 4-year follow-up of the MSC-HF trial.
Eur J Heart Fail. 2020 May;22(5):884-892. doi: 10.1002/ejhf.1700. Epub 2019 Dec 21.
10
A realistic appraisal of the use of embryonic stem cell-based therapies for cardiac repair.
Eur Heart J. 2020 Jul 1;41(25):2397-2404. doi: 10.1093/eurheartj/ehz787.
Zotero 插件